Treatment uptake among individuals notified with HCV infection 1990–2022 in Sweden
Sweden has reached the WHO treatment target, with treatment uptake ≥80%. In recent years, the median time to treatment has decreased to a few months. Continued efforts are needed to maintain this progress, particularly among people who inject drugs where HCV incidence remains high.
Authors
- Karin Lindahl (ORCID: https://orcid.org/0000-0002-3759-8603)
- Soo Aleman (ORCID: https://orcid.org/0000-0003-0461-4870)
- Charlotte Lybeck (ORCID: https://orcid.org/0000-0001-6711-0499)
- Olav Dalgård (ORCID: https://orcid.org/0000-0003-4470-3181)
- Martin Kåberg (ORCID: https://orcid.org/0000-0001-6643-3245)
- Caroline Gahrton (ORCID: https://orcid.org/0000-0003-2787-8481)
- Snehal Patil
- Ann‐Sofi Duberg
Institutions
- Oslo University Hospital (NO)
- Karolinska University Hospital (SE)
- Örebro University (SE)
- Akershus University Hospital (NO)
- Karolinska Institutet (SE)
- Integrated Cardio Metabolic Centre (SE)
- Centre for Palaeogenetics (SE)
Publication Details
- Journal
- Infectious Diseases
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1080/23744235.2025.2569504
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00